Results 111 to 120 of about 5,354,989 (174)

Clinical Translation of Patient‐Derived Organoids: Perspectives for Personalized Therapy in Cancer

open access: yesInternational Journal of Cancer, Volume 160, Issue 2, Page 227-240, 15 January 2027.
ABSTRACT Patient‐derived organoids (PDO) are accelerating precision medicine. These biological platforms allow for the autologous in vitro expansion of material from cancer patients in a considerably short period of time. These three‐dimensional models can faithfully recapitulate aspects of tissue heterogeneity, architecture, and relevant cellular ...
Haiyan Yue   +6 more
wiley   +1 more source

Association of Prophylactic Abdominal Drain Placement With Short‐Term Postoperative Outcomes After Hepatectomy: A Nationwide Inpatient Database Study in Japan

open access: yesAnnals of Gastroenterological Surgery, Volume 11, Issue 1, January 2027.
ABSTRACT Aim Although randomized trials have discouraged routine prophylactic abdominal drainage after uncomplicated hepatectomy, these drains are still widely used in clinical practice. This study evaluated the association between prophylactic abdominal drain placement and short‐term outcomes after hepatic resection using a nationwide inpatient ...
Keita Kouzu   +17 more
wiley   +1 more source

Impact of Laparoscopic Liver Resection on Long‐Term Outcomes and Non‐Liver‐Related Mortality in Elderly Patients With Primary Hepatocellular Carcinoma: A Multicenter Propensity Score‐Matched Analysis

open access: yesAnnals of Gastroenterological Surgery, Volume 11, Issue 1, January 2027.
In this multicenter, propensity score–matched study of elderly patients with primary hepatocellular carcinoma, we compared long‐term cause‐specific mortality between laparoscopic (LLR) and open liver resection (OLR) using a competing‐risks framework. Among patients aged ≥ 80 years, LLR was associated with a lower 5‐year cumulative incidence of death ...
Yukio Tokumitsu   +19 more
wiley   +1 more source

Prediction of Long‐Term Prognosis in Patients With Hepatocellular Carcinoma Using the National Clinical Database Risk Calculator

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 6, Page 1780-1787, November 2026.
This study aimed to determine the value of the National Clinical Database (NCD) risk calculator in predicting surgical outcomes and long‐term prognosis in patients undergoing resection for hepatocellular carcinoma (HCC). We retrospectively analyzed data from 210 patients with HCC who underwent initial hepatic resection, assessing the relationship ...
Mariko Tsukagoshi   +8 more
wiley   +1 more source

Preoperative FIB‐4 Index as a Potential Factor Associated With Severe Postoperative Complications and Endogenous Organ Failure After Hepatectomy for Hepatocellular Carcinoma

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 6, Page 1798-1809, November 2026.
This study demonstrates that a preoperative FIB‐4 index ≥ 5.0 independently predicts severe complications and endogenous organ failure (EOF) following hepatectomy for hepatocellular carcinoma. By capturing structural liver fragility and systemic vulnerability, the FIB‐4 index enhances surgical risk stratification beyond traditional functional markers ...
Masanori Nakamura   +9 more
wiley   +1 more source

Surgical Management and Outcomes of Relapsed and Refractory Hepatoblastoma: An Institutional Case Series

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Relapse occurs in 10%–20% of children with hepatoblastoma and is associated with inferior outcomes, yet standardized management remains limited. Defining risk factors and relapse patterns, as well as the role of surgery, particularly transplantation, is critical to optimizing survival. A retrospective review was performed of patients aged 0–18 
Marissa Ray   +14 more
wiley   +1 more source

Major Hepatectomies for Hepatocellular Carcinoma

open access: yes, 2022
Giammauro Berardi   +3 more
openaire   +1 more source

Pathological Complete Response and Successful Conversion Hepatectomy in Initially Unresectable Giant Hepatocellular Carcinoma Following Triple Therapy With HAIC, Bevacizumab, and Tislelizumab: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Severe future liver remnant (FLR) deficiency frequently renders giant hepatocellular carcinoma (HCC) unresectable. We report a 48‐year‐old man with an unresectable 23.5‐cm giant HCC (Couinaud segments 4/5/8; baseline serum alpha‐fetoprotein (AFP), 1036.65 μg/L).
Qing Ye   +5 more
wiley   +1 more source

Inflammatory Markers and Outcomes After Liver Resection for Colorectal Liver Metastases

open access: yesCancer Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background and Objectives The liver is the main site of colorectal metastatic disease. This study evaluated the association of Neutrophil‐to‐Lymphocyte Ratio (NLR), Platelet‐to‐Lymphocyte Ratio (PLR), and Monocyte‐to‐Lymphocyte Ratio (MLR) among patients with colorectal liver metastases (CRLM) undergoing liver resection.
Rider May Cedro   +8 more
wiley   +1 more source

Assessment of liver function before major hepatectomy

open access: yesBritish Journal of Surgery, 2023
Arntz, Pieter, Olthof, Pim B.
openaire   +2 more sources

Home - About - Disclaimer - Privacy